ARTICLE | Politics, Policy & Law
Defense bill places biotech under national security umbrella
By Steve Usdin, Washington Editor
December 9, 2024 10:22 PM UTC
Congress’ decision against adding the Biosecure Act to the National Defense Authorization Act reduces the odds that the legislation will become law this year, but lawmakers have not abandoned their intent to reduce U.S. reliance on Chinese biopharmaceutical manufacturing and services providers. The NDAA draft released Saturday evening contains multiple provisions aimed at enhancing U.S. biotech supply chain resilience.
Two of the four lawmakers with power over NDAA provisions, Sen. Rand Paul (R-Ky.) and Rep. Jamie Raskin (D-Md.), refused to sign off on inclusion of the anti-China biotech bill in the defense bill…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654412/biosecure-setback-amid-lawmakers-push-to-reduce-reliance-on-china